Search Results

• • 12 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Exercise training reverses endothelial dysfunction in nonalcoholic fatty liver disease

  Authors:Christopher J.A. Pugh, Victoria S. Sprung, Graham J. Kemp, Paul Richardson, Fariba Shojaee-Moradie, A. Margot Umpleby, et al.From:American Journal of Physiology (Consolidated) (Vol. 307, Issue 5) Peer-Reviewed

  Nov. 2014332 words Author abstract, Rep...

   Abstract Only

• Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes.

  Authors:Tero Saukkonen, Fariba Shojaee-Moradie, Rachel M. Williams, Rakesh Amin, Kevin C. Yuen, Angie Watts, et al.From:Diabetes (Vol. 55, Issue 8) Peer-Reviewed

  Aug. 20064,071 words Article 1760LRecombinant human IGF-I (rhIGF-I) complexed with its natural binding protein IGF-binding protein (IGFBP)-3 (rhIGF-I/IGFBP-3) is a novel formulation that has been shown to improve insulin sensitivity in type 1 diabetes,...

• Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1[beta] and -1[alpha] mutations

  Authors:Anna Brackenridge, Ewan R. Pearson, Fariba Shojaee-Moradie, Andrew T. Hattersley, David Russell-Jones, and A. Margot UmplebyFrom:Diabetes (Vol. 55, Issue 2) Peer-Reviewed

  Feb. 20065,183 words Article Heterozygous mutations in the transcription factors hepatocyte nuclear factor (HNF)-1[alpha] and -1[beta] result in MODY (maturity-onset diabetes of the young). Despite structural similarity between HNF-1[alpha] and...

• Insulin detemir reduces weight gain as a result of reduced food intake in patients with type 1 diabetes

  Authors:Sunil Zachariah, Ben Sheldon, Fariba Shojaee-Moradie, Nicola C. Jackson, Katharine Backhouse, Sigurd Johnsen, et al.From:Diabetes Care (Vol. 34, Issue 7) Peer-Reviewed

  July 20114,075 words Report 1450LOBJECTIVE--Insulin detemir lacks the usual propensity for insulin to cause weight gain. We investigated whether this effect was a result of reduced energy intake and/or increased energy expenditure. RESEARCH DESIGN...

• Prandial hypertriglyceridemia in metabolic syndrome is due to an overproduction of both chylomicron and VLDL triacylglycerol

  Authors:Fariba Shojaee-Moradie, Yuying Ma, Shaoying Lou, Roman Hovorka, and A. Margot UmplebyFrom:Diabetes (Vol. 62, Issue 12) Peer-Reviewed

  Dec. 20135,228 words Report 1470LThe aim was to determine whether fed VLDL and chylomicron (CM) triacylglycerol (TAG) production rates are elevated in metabolic syndrome (MetS). Eight men with MetS (BMI 29.7 [+ or -] 1.1) and eight lean age-matched...

• The SGLT2 Inhibitor Dapagliflozin Increases the Oxidation of Ingested Fatty Acids to Ketones in Type 2 Diabetes.

  Authors:Roselle Herring, Fariba Shojaee-Moradie, Mary Stevenage, Iain Parsons, Nicola Jackson, Jeewaka Mendis, et al.From:Diabetes Care (Vol. 45, Issue 6) Peer-Reviewed

  June 2022 Report

   Citation Only

• Prandial Hypertriglyceridemia in Metabolic Syndrome Is Due to an Overproduction of Both Chylomicron and VLDL Triacylglycerol

  Authors:Fariba Shojaee-Moradie, Yuying Ma, Shaoying Lou, Roman Hovorka, and A. Margot UmplebyFrom:Diabetes (Vol. 63, Issue 2) Peer-Reviewed

  Feb. 201456 words Brief article, Corre... 1050LPrandial Hypertriglyceridemia in Metabolic Syndrome Is Due to an Overproduction of Both Chylomicron and VLDL Triacylglycerol. Diabetes 2013;62:4063-4069 DOI: 10.2337/db14-er02a In the Acknowledgments of the...

• A novel method for measuring intestinal and hepatic triacylglycerol kinetics

  Authors:Feifei Sun, Mike Stolinski, Fariba Shojaee-Moradie, Shaoying Lou, Yuying Ma, Roman Hovorka, et al.From:American Journal of Physiology (Consolidated) (Vol. 305, Issue 4) Peer-Reviewed

  Oct. 2013260 words Author abstract, Rep...

   Abstract Only

• Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes.

  Authors:Roselle A. Herring, Fariba Shojaee-Moradie, Robert Garesse, Mary Stevenage, Nicola Jackson, Barbara A. Fielding, et al.From:Diabetes Care (Vol. 43, Issue 9) Peer-Reviewed

  Sept. 2020 Report

   Citation Only

• Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT

  Authors:Roman Hovorka, Fariba Shojaee-Moradie, Paul V. Carroll, Ludovich Chassin, Ian J. Gowrie, Nicola C. Jackson, et al.From:American Journal of Physiology (Consolidated) (Vol. 282, Issue 5) Peer-Reviewed

  May 2002378 words Abstract

   Abstract Only

• Novel Hepatoselective Insulin Analog

  Authors:FARIBA SHOJAEE-MORADIE, JAMES K. POWRIE, ERIK SUNDERMANN, MARK W. SPRING, ACHIM SCHUTTLER, DIETRICH BRANDENBURG, et al.From:Diabetes Care (Vol. 23, Issue 8) Peer-Reviewed

  Aug. 20004,482 words Article Studies with a covalently linked thyroxyl-insulin complex in humans OBJECTIVE -- To test whether a thyroxyl-insulin analog with restricted access to receptor sites in peripheral tissues displays relative...

• The fat mass and obesity-associated (FTO) gene allele rs9939609 and glucose tolerance, hepatic and total insulin sensitivity, in adults with obesity.

  Authors:Ann Kristin Hjelle de Soysa, Mette Langaas, Anida Jakic, Fariba Shojaee-Moradie, A. Margot Umpleby, Valdemar Grill, et al.From:PLoS ONE (Vol. 16, Issue 3) Peer-Reviewed

  Mar. 8, 20218,349 words Report 1480LThe objective of the study was to assess associations of the rs9939609 FTO allele to glucose tolerance, hepatic and total insulin sensitivity (IS) in individuals with obesity. From a low-dose hyperinsulinemic euglycemic...